INTRODUCTION
The immune system is capable of recognizing and rejecting autologous tumor cells. This is suggested by reported cases of spontaneous remission of various cancers (1) , and the presence of infiltrating leukocytes, the majority of which consist of T cells. However, the very existence of cancer and its inevitable progression without treatment demonstrates the inefficiency of the natural immune defence in combating tumors, and the ability of neoplastic cells to evade immune-surveillance. Thus, the major objectives of immunotherapeutic approaches to the treatment of cancer rely on the ability to augment adaptive and natural immune responses against malignant cells.
During the last decade a great deal of attention has been paid to the role of dendritic cells (DCs) in the development of immune responses; the ultimate aim being to provide a novel means of cancer therapy for patients. DCs directly isolated from patients' blood have already been shown to be effective in promoting anti-tumor immunity in pilot clinical trials (2), and such approaches are likely to be effective in patients who have completed conventional anti-tumor therapies (surgery, chemotherapy, radiotherapy) and who have minimal residual disease. By reducing tumor bulk prior to immunotherapy the degree of tumor "fight back" will be reduced and the efficiency of the immune response most likely enhanced.
DCs pulsed with specific tumor peptide are also able to activate either CD4 + or CD8 + specific Tcell responses (17, 18, 19 Here we present a simple method to generate immature and mature DCs.
For clinical purposes DCs have to be generated without the use of foreign proteins, in particular xenogenic proteins present in fetal calf serum (FCS). However we, along with Pietschmann and co-workers (24), have found that DCs generated in medium containing 1% autologous serum and GM-CSF and IL-4 for 6 days and TNF-α for another two days expressed significantly lower CD40, CD1a and CD54 cell surface markers than DCs cultures in FCS-containing medium.
Culturing DCs in autologous serum instead of 10% FCS induced morphological changes including the absence of aggregate formation and a reduced activity in mixed lymphocyte reaction (MLR) assays. Their ability to phagocytose latex beads was comparable and both were capable of inducing T cells proliferation after incubation with 0.5 µg/mL of tetanus toxoid protein.
The following methods can be used to generate DCs and assess their phenotypic and functional properties.
MATERIALS

Medium
The medium used throughout the study was RPMI 1640 supplemented with 200 mmol/L Lglutamine and with the addition of either 10% fetal calf serum (FCS) or 1% autologous serum (heat inactivated 56°C for 30 minutes).
Other Reagents
• Blocking buffer: 1 x PBS + 0.1% bovine serum albumin (BSA) and 0.02% sodium azide, stored at room temperature.
• Sheath fluid: 6.38 g NaCl + 1 g Boric acid + 0.2 g EDTA-2K + 0.2 g sodium tetraborate, made up to 1 litre with distilled water and 0.5% formaldehyde added, stored at room temperature.
• Ficoll Hypaque, stored at room temperature.
• Propidium Iodine, stored at 4ºC.
• Fluorescence Mounting Media (Dako, Cambridge, U.K), stored at 4ºC.
• Tetanus Toxoid, Clostridium tétani (Calbiochem, Nottingham, U.K), stored at -80ºC in aliquots after reconstitution in sterile distilled water.
• Tritium labelled thymindine ( 3 H) (Amersham, Biotech, U.K)
The immature DCs were re-plated at 0.5 x 10 6 cells/mL per well of a 24-well plate in fresh media containing the relevant serum and 1000 U/mL GM-CSF, 500 U/mL IL-4 and 10 ng/mL of TNF- Generation of DCs in medium containing human plasma (preferably autologous) is required if they are to be used for human therapy. Significant differences in the immunnophenotype, macropinocytosis, endocytosis and activity in MLR have been reported for DCs generated in FCS versus human plasma (33, 34). In our hands, high yields, increased expression of co-stimulatory molecules and cell clustering during the first 3 days of culture were observed when PBMC were cultured in media supplemented with 10% FCS but not in 1% autologous plasma. A significant increase in the expression of CD1a, CD40 and CD54 was observed in DCs cultured in the presence of 10% FCS for 10 days in comparison to those cultured in autologous plasma; in addition, similar differences were noticed in functional assays using MLR.
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